NEW YORK--(BUSINESS WIRE)--Omrix Biopharmaceuticals, Inc. (“Omrix” or the “Company”) (NASDAQ: OMRI) announced today that Larry Ellberger was named Chairman of the Board of Directors (“Board”) and Pamela McNamara was elected a Director at the Company’s 2008 Annual Meeting of Stockholders held today in New York City.
